Hepatic stellate cells and the regulation of liver inflammation

Journal of Hepatology

Volumn 31, Issue 6, 1999, Pages 1120-1130

  Marra, Fabio ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA CHEMOKINE; BETA CHEMOKINE; CELL ADHESION MOLECULE; CHEMOKINE; COLONY STIMULATING FACTOR 1; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 1; INTERLEUKIN 10; INTERLEUKIN 6; INTERLEUKIN 8; LIPOPOLYSACCHARIDE; MONOCYTE CHEMOTACTIC PROTEIN 1; PLATELET DERIVED GROWTH FACTOR; STEM CELL FACTOR; THROMBOCYTE ACTIVATING FACTOR; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; VASCULAR CELL ADHESION MOLECULE 1;

CELL ADHESION; INFLAMMATION; ITO CELL; LIVER INJURY; NEUTROPHIL CHEMOTAXIS; PRIORITY JOURNAL; REGULATORY MECHANISM; REVIEW; WOUND HEALING;

EID: 0032731751     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(99)80328-6     Document Type: Letter

References (83)

1. Maher JJ, Bissell DM, Friedman SL, Roll FJ. Collagen measured in primary cultures of normal rat hepatocytes derives from lipocytes within the monolayer. J Clin Invest. 82:1988;450-459.
2. Milani S, Herbst H, Schuppan D, Hahn EG, Stein H. In situ hybridization for procollagen types I, III and IV mRNA in normal and fibrotic rat liver: evidence for predominant expression in nonparenchymal liver cells. Hepatology. 10:1989;84-92.
3. Friedman SL. The cellular basis of hepatic fibrosis. Mechanisms and treatment strategies. N Engl J Med. 328:1993;1828-1835.
4. Pinzani M. Hepatic stellate (ITO) cells: expanding roles for a liver-specific pericyte. J Hepatol. 22:1995;700-706.
5. Olaso E, Santisteban A, Bidaurrazaga J, Gressner AM, Rosenbaum J, Vidal-Vanaclocha F. Tumor-dependent activation of rodent hepatic stellate cells during experimental melanoma metastasis. Hepatology. 26:1997;634-642.
6. Springer TA. Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm. Cell. 76:1994;301-314.
7. Rosen SD. Cell surface lectins in the immune system. Semin Immunol. 5:1993;237-247.
8. Luster AD. Chemokines - chemotactic cytokines that mediate inflammation. N Engl J Med. 338:1998;436-445.
9. Baggiolini M, Dewald B, Moser B. Human chemokines: an update. Annu Rev Immunol. 15:1997;675-705.
10. Marra F, Valente AJ, Pinzani M, Abboud HE. Cultured human liver fat-storing cells produce monocyte chemotactic protein-1. Regulation by proinflammatory cytokines. J Clin Invest. 92:1993;1674-1680.
11. Czaja MJ, Geerts A, Xu J, Schmiedeberg P, Ju Y. Monocyte chemoattractant protein 1 (MCP-1) expression occurs in toxic rat liver injury and human liver disease. J Leukoc Biol. 55:1994;120-126.
12. Marra F, DeFranco R, Grappone C, Milani S, Pastacaldi S, Pinzani M, et al. Increased expression of monocyte chemotactic protein-1 during active hepatic fibrogenesis: correlation with monocyte infiltration. Am J Pathol. 152:1998;423-430.
13. Marra F, De Franco R, Grappone C, Parola M, Milani S, Leonarduzzi G, et al. Expression of monocyte chemotactic protein-1 precedes monocyte recruitment in a rat model of acute liver injury, and is modulated by vitamin E. J Investig Med. 47:1999;66-75.
14. Xu Y, Rojkind M, Czaja MJ. Regulation of monocyte chemoattractant protein 1 by cytokines and oxygen free radicals in rat hepatic fat-storing cells. Gastroenterology. 110:1996;1870-1877.
15. Sprenger H, Kaufmann A, Garn H, Lahme B, Gemsa D, Gressner AM. Differential expression of monocyte chemotactic protein-1 (MCP-1) in transforming rat hepatic stellate cells. J Hepatol. 30:1999;88-94.
16. Hellerbrand C, Jobin C, Licato LL, Sartor RB, Brenner DA. Cytokines induce NF-kappaB in activated but not in quiescent rat hepatic stellate cells. Am J Physiol. 275:1998;G269-G278.
17. Kaplowitz N, Tsukamoto H. Oxidative stress and liver disease. Prog Liver Dis. 14:1996;131-159.
18. Kharbanda KK, Todero SL, Sorrell MF, Tuma DJ. MAA adducts increas chemokine production and the expression of cell adhesion molecule, ICAM-1, in hepatic stellate cells. [abstract] Hepatology. 28:1998;311A.
19. Marra F, Pastacaldi S, Romanelli RG, Pinzani M, Ticali P, Carloni V, et al. Integrin-mediated stimulation of monocyte chemotactic protein-1 expression. FEBS Lett. 414:1997;221-225.
20. Cochran BH, Reffel AC, Stiles CD. Molecular cloning of gene sequences regulated by platelet-derived growth factor. Cell. 33:1983;939-947.
21. Marra F, Valente AJ, Grandaliano G, Abboud HE. Thrombin stimulates proliferation of liver fat-storing cells and expression of monocyte chemotactic protein-1. Potential role in liver injury. Hepatology. 22:1995;780-787.
22. Dery O, Corvera CU, Steinhoff M, Bunnett NW. Proteinase-activated receptors: novel mechanisms of signaling by serine proteases. Am J Physiol. 274:1998;C1429-C1452.
23. Marra F, DeFranco R, Grappone C, Milani S, Pinzani M, Pellegrini G, et al. Expression of the thrombin receptor in human liver: upregulation during acute and chronic injury. Hepatology. 27:1998;462-471.
24. Gaç MDA, Arthur MJP, Benyon RC. Detection of proteinase activated receptors in rat liver and hepatic stellate cells. [abstract] J Hepatol. 30:(Suppl.1):1999;64.
25. MAPK is required for cytokine-stimulated expression of monocyte chemotactic protein-1. [abstract] Hepatology. 26:1997;184A.
26. Shecter AD, Rollins BJ, Zhang YJ, Charo IF, Fallon JT, Rossikhina M, et al. Tissue factor is induced by monocyte chemoattractant protein-1 in human aortic smooth muscle and THP-1 cells. J Biol Chem. 272:1997;28568-28573.
27. Marra F, Romanelli RG, Giannini C, Failli P, Pastacaldi S, Arrighi MC, et al. Monocyte chemotactic protein-1 as a chemoattractant for human hepatic stellate cells. Hepatology. 29:1999;140-148.
28. Yamaguchi Y, Ichiguchi O, Matsumura F, Akizuki E, Matsuda T, Okabe K, et al. Enhanced expression of cytokine-induced neutrophil chemoattractant in rat hepatic allografts during acute rejection. Hepatology. 26:1997;1546-1552.
29. Lentsch AB, Yoshidome H, Cheadle WG, Miller FN, Edwards MJ. Chemokine involvement in hepatic ischemia/reperfusion injury in mice: roles for macrophage inflammatory protein-2 and KC. Hepatology. 27:1998;1172-1177.
30. Sheron N, Bird G, Koskinas J, Portmann B, Ceska M, Lindley I, et al. Circulating and tissue levels of the neutrophil chemotaxin interleukin-8 are elevated in severe acute alcoholic hepatitis, and tissue levels correlate with neutrophil infiltration. Hepatology. 18:1993;41-46.
31. Maltby J, Wright S, Bird G, Sheron N. Chemokine levels in human liver homogenates: associations between GRO alpha and histopathological evidence of alcoholic hepatitis. Hepatology. 24:1996;1156-1160.
32. Maher JJ, Scott MK, Saito JM, Burton MC. Adenovirus-mediated expression of cytokine-induced neutrophil chemoattractant in rat liver induces a neutrophilic hepatitis. Hepatology. 25:1997;624-630.
33. Sprenger H, Kaufmann A, Garn H, Lahme B, Gemsa D, Gressner AM. Induction of neutrophil-attracting chemokines in transforming rat hepatic stellate cells. Gastroenterology. 113:1997;277-285.
34. Barnes PJ, Karin M. Nuclear factor-kappaB: a pivotal transcription factor in chronic inflammatory diseases. N Engl J Med. 336:1997;1066-1071.
35. Lee KS, Buck M, Houglum K, Chojkier M. Activation of hepatic stellate cells by TGF alpha and collagen type I is mediated by oxidative stress and through c-myb expression. J Clin Invest. 96:1995;2461-2468.
36. Maher JJ. Rat hepatocytes and Kupffer cells interact to produce interleukin-8 (CINC) in the setting of ethanol. Am J Physiol. 269:1995;G518-G523.
37. Maher JJ, Lozier JS, Scott MK. Rat hepatic stellate cells produce cytokine-induced neutrophil chemoattractant in culture and in vivo. Am J Physiol. 275:1998;G847-G853.
38. Narumi S, Tominaga Y, Tamaru M, Shimai S, Okumura H, Nishioji K, et al. Expression of IFN-inducible protein-10 in chronic hepatitis. J Immunol. 158:1997;5536-5544.
39. Efsen E, Caligiuri A, Romanelli RG, Grappone C, DeFranco R, Milani S, et al. Increased expression of fractalkine, a novel chemokine, during liver injury: role in recruitment and adhesion of leukocytes. [abstract] J Hepatol. 30:(Suppl.1):1999;89.
40. Pinzani M, Carloni V, Marra F, Riccardi D, Laffi G, Gentilini P. Biosynthesis of platelet-derived growth factor and its 1O-acyl analogue by liver fat-storing cells. Gastroenterology. 106:1994;1301-1311.
41. Frank MM. Complement in the pathophysiology of human disease. N Engl J Med. 316:1987;1525-1530.
42. Schwogler S, Odenthal M, Knittel T, Meyer zum Büschenfelde KH, Ramadori G. Fat-storing cells of the rat liver synthesize and secrete C1-esterase inhibitor; modulation by cytokines. Hepatology. 16:1992;794-802.
43. Fimmel CJ, Brown KE, O'Neill R, Kladney RD. Complement C4 protein expression by rat hepatic stellate cells. J Immunol. 157:1996;2601-2609.
44. Schieferdecker HL, Rothermel E, Timmermann A, Gotze O, Jungermann K. Anaphylatoxin C5a receptor mRNA is strongly expressed in Kupffer and stellate cells and weakly in sinusoidal endothelial cells but not in hepatocytes of normal rat liver. FEBS Lett. 406:1997;305-309.
45. Hellerbrand C, Wang SC, Tsukamoto H, Brenner DA, Rippe RA. Expression of intracellular adhesion molecule 1 by activated hepatic stellate cells. Hepatology. 24:1996;670-676.
46. Springer TA. Adhesion receptors of the immune system. Nature. 346:1990;425-434.
47. Knittel T, Dinter C, Kobold D, Neubauer K, Mehde M, Eichhorst S, et al. Expression and regulation of cell adhesion molecules by hepatic stellate cells (HSC) of rat liver: involvement of HSC in recruitment of inflammatory cells during hepatic tissue repair. Am J Pathol. 154:1999;153-167.
48. Knittel T, Aurisch S, Neubauer K, Eichhorst S, Ramadori G. Cell-type-specific expression of neural cell adhesion molecule (N-CAM) in Ito cells of rat liver. Up-regulation during in vitro activation and in hepatic tissue repair. Am J Pathol. 149:1996;449-462.
49. Cunningham B. Cell adhesion molecules as morphoregulators. Curr Opin Cell Biol. 7:1995;628-633.
50. Moore K, O'Gaara A, de Waal Malefyt R, Vieira P, Mosman T. Interleukin-10. Annu Rev Immunol. 11:1993;165-190.
51. Knolle P, Schlaak J, Uhrig A, Kempf P, Meyer zum Büschenfelde KH, Gerken G. Human Kupffer cells secrete IL-10 in response to lipopolysaccharide (LPS) challenge. J Hepatol. 22:1995;226-229.
52. Thompson K, Maltby J, Fallowfield J, McAulay M, Millward-Sadler H, Sheron N. Interleukin-10 expression and function in experimental murine liver inflammation and fibrosis. Hepatology. 28:1998;1597-1606.
53. Kühn R, Löhrer J, Rennick D, Rajevski K, Müller W. Interleukin-10-deficient mice develop chronic enterocolitis. Cell. 75:1993;263-274.
54. Wang SC, Ohata M, Schrum L, Rippe RA, Tsukamoto H. Expression of interleukin-10 by in vitro and in vivo activated hepatic stellate cells. J Biol Chem. 273:1998;302-308.
55. Thompson KC, Trowern A, Fowell A, Marathe M, Haycock C, Arthur MJ, et al. Primary rat and mouse hepatic stellate cells express the macrophage inhibitor cytokine interleukin-10 during the course of activation in vitro. Hepatology. 28:1998;1518-1524.
56. Louis H, Van Laethem JL, Wu W, Quertinmont E, Degraef C, Van den Berg K, et al. Interleukin-10 controls neutrophilic infiltration, hepatocyte proliferation, and liver fibrosis induced by carbon tetrachloride in mice. Hepatology. 28:1998;1607-1615.
57. Wynn TA, Cheever AW, Williams ME, Hieny S, Caspar P, Kuhn R, et al. IL-10 regulates liver pathology in acute murine Schistosomiasis mansoni but is not required for immune down-modulation of chronic disease. J Immunol. 160:1998;4473-4480.
58. Pinzani M, Abboud HE, Gesualdo L, Abboud SL. Regulation of macrophage colony-stimulating factor in liver fat-storing cells by peptide growth factors. Am J Physiol. 262:1992;C876-C881.
59. Fixe P, Praloran V. M-CSF: haematopoietic growth factor or inflammatory cytokine? Cytokine. 10:1998;32-37.
60. Seelentag WK, Mermod JJ, Montesano R, Vassalli P. Additive effects of interleukin 1 and tumour necrosis factor-alpha on the accumulation of the three granulocyte and macrophage colonystimulating factor mRNAs in human endothelial cells. EMBO J. 6:1987;2261-2265.
61. Matsui Y, Zsebo KM, Hogan BLM. Embryonic expression of a hematopoietic growth factor encoded by the S1 locus and the ligand for c-kit. Nature. 347:1990;369-375.
62. Tsai M, Takeishi T, Thompson H, Langley KE, Zsebo KM, Metcalfe DD, et al. Induction of mast cell proliferation, maturation, and heparin synthesis by the rat c-kit ligand, stem cell factor. Proc Natl Acad Sci USA. 88:1991;6382-6386.
63. Fujio K, Evarts RP, Hu Z, Marsden ER, Thorgeirsson SS. Expression of stem cell factor and its receptor, c-kit, during liver regeneration from putative stem cells in adult rat. Lab Invest. 70:1994;511-516.
64. Armbrust T, Batusic D, Ringe B Ramadori G. Mast cell distribution in human liver disease and experimental rat liver fibrosis. Indications for mast cell participation and development of liver fibrosis. J Hepatol. 26:1997;1042-1054.
65. Farrell DJ, Hines JE, Walls AF, Kelly PJ, Bennett MK, Burt AD. Intrahepatic mast cells in chronic liver diseases. Hepatology. 22:1995;1175-1181.
66. Okazaki T, Hirota S, Xu ZD, Maeyama K, Nakama A, Kawano S, et al. Increase of mast cells in the liver and lung may be associated with but not a cause of fibrosis: demonstration using mast cell-deficient Ws/Ws rats. Lab Invest. 78:1998;1431-1438.
67. Sugihara A, Tsujimura T, Fujita Y, Nakata Y, Terada N. Evaluation of the role of mast cells in the development of liver fibrosis using mast cell-deficient rats and mice. J Hepatol. 30:1999;859-867.
68. Brito JM, Borojevic R. Liver granulomas in schistosomiasis: mast cell-dependent induction of SCF expression in hepatic stellate cells is mediated by TNF-alpha. J Leukoc Biol. 62:1997;389-396.
69. Gaça MDA, Pickering JA, Arthur MJP, Benyon RC. Human and rat hepatic stellate cells produce stem cell factor: a possible mechanism for mast cell recruitment in liver fibrosis. J Hepatol. 30:1999;850-858.
70. Steel DM, Whitehead AS. The major acute phase reactants: Creactive protein, serum amyloid P component and serum amyloid A protein. Immunol Today. 15:1994;81-88.
71. Danielpour D, Sporn MB. Differential inhibition of transforming growth factor beta 1 and beta 2 activity by alpha 2-macroglobulin. J Biol Chem. 265:1990;6973-6977.
72. Busam KJ, Bauer TM, Bauer J, Gerok W, Decker K. Interleukin-6 release by rat liver macrophages. J Hepatol. 11:1990;367-373.
73. 4-cirrhotic livers. Differences in the production of interleukin-6. Lab Invest. 65:1991;644-653.
74. 4-cirrhotic rat are heterogeneous with regard to proliferation, expression of extracellular matrix components, interleukin-6, and connexin 43. Lab Invest. 69:1993;210-216.
75. Tiggelman AM, Boers W, Linthorst C, Brand HS, Sala M, Chamuleau RA. Interleukin-6 production by human liver (myo)-fibroblasts in culture. Evidence for a regulatory role of LPS, IL-1 beta and TNF alpha. J Hepatol. 23:1995;295-306.
76. Kawashima R, Mochida S, Matsui A, YouLuTuZ Y, Ishikawa K, Toshima K, et al. Expression of osteopontin in Kupffer cells and hepatic macrophages and stellate cells in rat liver after carbon tetrachloride intoxication: a possible factor for macrophage migration into hepatic necrotic areas. Biochem Biophys Res Commun. 256:1999;527-531.
77. Mallat A, Fouassier L, Preaux AM, Gal CS, Raufaste D, Rosenbaum J, et al. Growth inhibitory properties of endothelin-1 in human hepatic myofibroblastic Ito cells. An endothelin B receptor-mediated pathway. J Clin Invest. 96:1995;42-49.
78. Hernandez-Munoz I, de la Torre P, Sanchez-Alcazar JA, Garcia I, Santiago E, Munoz-Yague MT, et al. Tumor necrosis factor alpha inhibits collagen alpha 1(I) gene expression in rat hepatic stellate cells through a G protein. Gastroenterology. 113:1997;625-640.
79. Pinzani M, Failli P, Ruocco C, Casini A, Milani S, Baldi E, et al. Fat-storing cells as liver-specific pericytes. Spatial dynamics of agonist-stimulated intracellular calcium transients. J Clin Invest. 90:1992;642-646.
80. Emilie D, Galanaud P. Cytokines and chemokines in HIV infection: implications for therapy. Int Rev Immunol. 16:1998;705-726.
81. Gröne H-J, Weber C, Gröne EF, Weber KSC, Klier C, Wells TNC, et al. Met-RANTES reduces vascular and tubular damage during acute renal transplant rejection: blocking monocyte arrest and recruitment. FASEB J. 1999;. in press.
82. Hellerbrand C, Jobin C, Iimuro Y, Licato L, Sartor RB, Brenner DA. Inhibition of NFkappaB in activated rat hepatic stellate cells by proteasome inhibitors and an IkappaB super-repressor. Hepatology. 27:1998;1285-1295.
83. Iimuro Y, Nishiura T, Hellerbrand C, Behrns KE, Schoonhoven R, Grisham JW, et al. NFkappaB prevents apoptosis and liver dysfunction during liver regeneration. J Clin Invest. 101:1998;802-811.